Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Ovarian cancer is often diagnosed late because its symptoms resemble those of less serious conditions. As a result, only 20% ...

The NHS has teamed up with the Dianne Oxberry Trust and Target Ovarian Cancer to bring a new awareness roadshow to the streets of Greater Manchester – including Wigan and Leigh – this March for ...

Ovarian cancer may present a threat to the fallopian tubes and peritoneum. Oncologists Dr. Sai Lakshmi Daayana and Dr. Ajay ...

Ovarian cancer affects anyone with ovaries, most commonly women who are older than 50, the NHS explains - here are the ...